Acute myocardial infarction in a 24 year-old man possibly associated with sibutramine use

International Journal of Cardiology

Volumn 137, Issue 2, 2009, Pages

  Eroglu, Elif ^a   Gemici, Gokmen ^a   Bayrak, Fatih ^a   Kalkan, Ali Kemal ^a   Degertekin, Muzaffer ^a  

^a YEDITEPE UNIVERSITY   (Turkey)

Author keywords

Acute myocardial infarction; Noradrenaline; Obesity; Sibutramine

Indexed keywords

SIBUTRAMINE;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CORONARY ARTERY THROMBOSIS; DRUG EFFECT; DRUG USE; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; PRIORITY JOURNAL; SYMPTOM; THORAX PAIN;

CYCLOBUTANES; HUMANS; MALE; MYOCARDIAL INFARCTION; YOUNG ADULT;

EID: 70349448624     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.06.017     Document Type: Article

References (13)

1. Arterburn D.E., Crane P.K., and Veenstra D.L. The efficacy and safety of sibutramine for weight loss: a systematic review. Arch Intern Med 164 (2004) 994-1003
2. James W.P., Astrup A., Finer N., et al. Effect of sibutramine on weight maintenance after weight loss: a randomised trial. STORM Study Group. Sibutramine trial of obesity reduction and maintenance. Lancet 356 (2000) 2119-2125
3. Gokcel A., Gumurdulu Y., Karakose H., et al. Evaluation of the safety and efficacy of sibutramine, orlistat and metformin in the treatment of obesity. Diabetes Obes Metab 4 (2002) 49-55
4. Coulter D. The New Zealand Intensive Medicines Monitoring Programme in pro-active safety surveillance. Pharmacoepidemiol Drug Saf 9 (2000) 273-280
5. Harrison-Woolrych M., Clark D.W., Hill G.R., Rees M.I., and Skinner J.R. QT interval prolongation associated with sibutramine treatment. Br J Clin Pharmacol 61 (2006) 464-469
6. Narkiewicz K. Sibutramine and its cardiovascular profile. Int J Obes Relat Metab Disord 26 (2002) 38-41
7. Florentin M., Liberopoulos E.N., and Elisaf M.S. Sibutramine-associated adverse effects: a practical guide for its safe use. Obes Rev (2007 Nov 23) [Electronic publication ahead of print]
8. Muller J.E., Tofler G.H., and Stone P.H. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation 79 (1989) 733-743
9. Muller J.E., Abela G.S., Nesto R.W., and Tofler G.H. Triggers, acute risk factors and vulnerable plaques: the lexicon of a new frontier. J Am Coll Cardiol 23 (1994) 809-813
10. Culić V. Acute risk factors for myocardial infarction. Int J Cardiol 117 (2007 Apr 25) 260-269
11. Azarisman S.M., Magdi Y.A., Noorfaizan S., and Oteh M. Myocardial infarction induced by appetite suppressants in Malaysia. N Engl J Med 357 (2007) 1873-1874
12. Wooltorton E. Obesity drug sibutramine (Meridia): hypertension and cardiac arrhythmias. CMAJ 166 (2002) 1307-1308
13. Coats A.J. Ethical authorship and publishing. Int J Cardiol 131 (2009) 149-150